Professor Yazdan Yazdanpanah, head of the infectious and tropical diseases department at Bichat hospital in Paris, anticipates an influx of coronavirus patients next week. On Europe 1, he warns of the risk of seeing hospitals in the Paris region saturated.

Just because containment has been put in place does not mean that the number of coronavirus cases in France will drop immediately. This is what all doctors agree on. Because of the incubation time of the virus, and because the social distancing measures were not respected before the implementation of very restrictive measures (they are not always always afterwards), patients will continue to flock to hospitals in the coming days.

"We will do everything to make hospitals last"

"For this weekend, it will hold [in Île-de-France]. We will do everything to make it last", assures Europe 1 Yazdan Yazdanpanah, head of the infectious and tropical diseases department of Bichat hospital and Director of the Institute of Infectious Disease at Inserm. "But in a week, next week, it will be complicated." The first results of containment should really be felt in three weeks.

>> Watch Matthieu Belliard's morning show in replay and in podcast here

One who is also an expert with the WHO reminds us: "In hospitals, there are people who work hard, with great courage, to try to run the hospital. We will go through complicated moments and precisely, to get there, the population must help us by respecting the "containment" measures.

Results of clinical trials "within a month or two"

>> LIVE - Coronavirus: follow the evolution of the situation Friday March 20

Out of the question, therefore, to overcome containment. "It’s an even more contagious virus than we thought. People have to try not to go out. It’s very difficult for people to understand because when you go walking, you feel like nothing happens. However, we can meet someone "and transmit the virus to him, warns Yazdan Yazdanpanah.

>> PODCAST - Coronavirus: find all the answers to your questions here

The prospect of having a vaccine is very distant, and that of having a treatment not so close either. "We are going to start on three, four tracks of potentially active drugs," said the doctor. "To know if they are active, we must evaluate them in clinical trials. We will see the results in a month or two." In the meantime, the authorities are betting on everyone's good citizenship.